跳至主要内容
临床试验/NCT05037994
NCT05037994已完成不适用

Ultrasound Guided Continuous Suprascapular Nerve Block With Oral Gabapentin For Pain Management In Patients With Frozen Shoulder

Zagazig University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Visual analogue scale

研究概览

简要总结

The patients will be randomly allocated into two equal groups (each 20 patients) using sealed opaque numbered envelopes:

Control Group (C Group) : Patients receive continuous US suprascapular nerve block only.

Gabapentin Group (G Group) : Patients receive continuous US suprascapular nerve block with oral gabapentin 300 mg once daily at bed time.

Both groups compared as regard:

Visual Analogue Scale Range of passive and active movements Patients satisfaction complication related to block The total dose of diclofenac sodium

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Body mass index ≥ 18 Kg/m2 ≤ 30Kg/m2
  • •ASA I, II or III.
  • •Cooperative patients.

排除标准

  • •local infection at site of injection.
  • •coagulopathy
  • •previous history of mental disorders or chronic drug abuse (opioids, tranquilizers)
  • •known hypersensitivity to any of the drugs used in the study.

研究组 & 干预措施

Control Group (C Group)

Placebo Comparator

Patients will receive continuous US suprascapular nerve block only.

干预措施: Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine (Procedure)

Gabapentin Group (G Group)

Experimental

Patients will receive continuous US suprascapular nerve block with oral gabapentin 300 mg once daily at bed time.

干预措施: Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine (Procedure)

结局指标

主要结局

Visual analogue scale

时间窗: 6 weeks

10cm line where zero means no pain and ten means worse imaginary pain

次要结局

  • Range of passive and active movements(6 weeks)
  • Patients satisfaction(6 weeks)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Amr Shaaban Elshafei

AMR SHAABAN ELSHAFEI

Zagazig University

研究点 (1)

Loading locations...

相似试验